Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2014 | Research article

Central effects of acetylsalicylic acid on trigeminal-nociceptive stimuli

Authors: Inga L Kröger, Arne May

Published in: The Journal of Headache and Pain | Issue 1/2014

Abstract

Background

Acetylsalicylic acid is one of the most used analgesics to treat an acute migraine attack. Next to the inhibitory effects on peripheral prostaglandin synthesis, central mechanisms of action have also been discussed.

Methods

Using a standardized model for trigeminal-nociceptive stimulation during fMRI scanning, we investigated the effect of acetylsalicylic acid on acute pain compared to saline in 22 healthy volunteers in a double-blind within-subject design. Painful stimulation was applied using gaseous ammonia and presented in a pseudo-randomized order with several control stimuli. All participants were instructed to rate the intensity and unpleasantness of every stimulus on a VAS scale. Based on previous results, we hypothesized to find an effect of ASA on central pain processing structures like the ACC, SI and SII as well as the trigeminal nuclei and the hypothalamus.

Results

Even though we did not find any differences in pain ratings between saline and ASA, we observed decreased BOLD signal changes in response to trigemino-nociceptive stimulation in the ACC and SII after administration of ASA compared to saline. This finding is in line with earlier imaging results investigating the effect of ASA on acute pain. Contrary to earlier findings from animal studies, we could not find an effect of ASA on the trigeminal nuclei in the brainstem or within the hypothalamic area.

Conclusion

Taken together our study replicates earlier findings of an attenuating effect of ASA on pain processing structures, which adds further evidence to a possibly central mechanism of action of ASA.

Available only for authorised users

Taneri Z, Petersen-Braun M: Double blind study of intravenous aspirin vs placebo in the treatment of acute migraine attacks. Schmerz 1995, 9: 124–129. doi:10.1007/BF02530130 10.1007/BF02530130CrossRefPubMed

Diener H-C, Lampl C, Reimnitz P, Voelker M: Aspirin in the treatment of acute migraine attacks. Expert Rev Neurother 2006, 6: 563–573. doi:10.1586/14737175.6.4.563 10.1586/14737175.6.4.563CrossRefPubMed

Kirthi V, Derry S, Moore RA: Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013, 4: CD008041. doi:10.1002/14651858.CD008041.pub3PubMed

Savi LT, Condello V, Bert F, Pinessi L: Prophylaxis of migraine with aura: a place for acetylsalicylic acid. J Headache Pain 2013, 14: P195. doi:10.1186/1129–2377–14-S1-P195PubMedCentral

Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971, 231: 232–235. doi:10.1038/10.1038/newbio231232a0

Smith JB, Willis AL: Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971, 231: 235–237. doi:10.1038/10.1038/newbio231235a0

Auriel E, Regev K, Korczyn AD: Chapter 38 - Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. In Handbook of Clinical Neurology. Edited by: José B, Ferro JM. Oxford: Elsevier; 2014:577–584.

Brunton L, Chabner BA, Knollman B: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, Auflage: 12. Auflage. Mcgraw-Hill Publ. Comp, New York; 2011.

Burian M, Geisslinger G: COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 2005, 107: 139–154. doi:10.1016/j.pharmthera.2005.02.004 10.1016/j.pharmthera.2005.02.004CrossRefPubMed

10.

Vane J: Towards a better aspirin. Nature 1994, 367: 215–216. doi:10.1038/367215a0 10.1038/367215a0CrossRefPubMed

11.

Rømsing J, Møiniche S: A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004, 48: 525–546. doi:10.1111/j.0001–5172.2004.00379.x 10.1111/j.0001-5172.2004.00379.xCrossRefPubMed

12.

Feldman M, McMahon AT: Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 2000, 132: 134–143. 10.7326/0003-4819-132-2-200001180-00008CrossRefPubMed

13.

Bromm B, Rundshagen I, Scharein E: Central analgesic effects of acetylsalicylic acid in healthy men. Arzneimittelforschung 1991, 41: 1123–1129.PubMed

14.

Shyu KW, Lin MT: Hypothalamic monoaminergic mechanisms of aspirin-induced analgesia in monkeys. J Neural Transmission 1985, 62: 285–293. doi:10.1007/BF01252242 10.1007/BF01252242CrossRef

15.

Ferreira SH, Lorenzetti BB, Corrêa FMA: Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978, 53: 39–48. doi:10.1016/0014–2999(78)90265–0 10.1016/0014-2999(78)90265-0CrossRefPubMed

16.

Bannwarth B, Demotes-Mainard F, Schaeverbeke T, Labat L, Dehais J: Central analgesic effects of aspirin-like drugs. Fund Clin Pharmacol 1995, 9: 1–7. doi:10.1111/j.1472–8206.1995.tb00258.x 10.1111/j.1472-8206.1995.tb00258.xCrossRef

17.

Kobal G, Hummel C, Nuernberg B, Brune K: Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions 1990, 29: 342–359. 10.1007/BF01966467CrossRefPubMed

18.

Chen ACN, Chapman CR: Aspirin analgesia evaluated by event-related potentials in man: Possible central action in brain. Exp Brain Res 1980, 39: 359–364. doi:10.1007/BF00239300CrossRefPubMed

19.

Kaube H, Hoskin KL, Goadsby PJ: Acetylsalicylic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat*. Eur J Neurol 1994, 1: 141–146. doi:10.1111/j.1468–1331.1994.tb00062.x 10.1111/j.1468-1331.1994.tb00062.xCrossRefPubMed

20.

Goadsby PJ, Hoskin KL, Kaube H: Autoradiographic evaluation of acetylsalicylic acid distribution in the brain-stem of the cat. In New Adances in Headache Research, vol 42. Edited by: Rose FC. London: Smith-Gordon; 1994:151–153.

21.

Maihöfner C, Ringler R, Herrndobler F, Koppert W: Brain imaging of analgesic and antihyperalgesic effects of cyclooxygenase inhibition in an experimental human pain model: a functional MRI study. European Journal of Neuroscience 2007, 26: 1344–1356. doi:10.1111/j.1460–9568.2007.05733.x 10.1111/j.1460-9568.2007.05733.xCrossRefPubMed

22.

Tfelt-Hansen P, Olesen J: Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984, 4: 107–111. 10.1046/j.1468-2982.1984.0402107.xCrossRefPubMed

23.

Diener HC, Eikermann A, Gessner U, Göbel H, Haag G, Lange R, May A, Müller-Schwefe G, Voelker M: Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 2004, 52: 50–56. doi:10.1159/000079544 10.1159/000079544CrossRefPubMed

24.

Kaube H, Hoskin KL, Goadsby PJ: Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache. J Head Face Pain 1993, 33: 541–544. doi:10.1111/j.1526–4610.1993.hed3310541.x 10.1111/j.1526-4610.1993.hed3310541.xCrossRef

25.

Sandrini M, Vitale G, Dondi M, Pini LA: Effects of acetylsalicylic acid on serotonin brain receptor subtypes. Gen Pharmacol 1995, 26: 737–741. 10.1016/0306-3623(94)00252-ICrossRefPubMed

26.

Herrndobler F, Koppert W, Ringler R, Maihöfner C: Modulation der kortikalen Schmerzverarbeitung durch Cyclooxygenase-Hemmung. Der Schmerz 2008, 23: 134–144. doi:10.1007/s00482–008–0732-yCrossRef

27.

Stankewitz A, Voit HL, Bingel U, Peschke C, May A: A new trigemino-nociceptive stimulation model for event-related fMRI. Cephalalgia 2010, 30: 475–485. doi:10.1111/j.1468–2982.2009.01968.xPubMed

28.

Rowland M, Riegelman S: Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. J Pharm Sci 1968, 57: 1313–1319. doi:10.1002/jps.2600570807 10.1002/jps.2600570807CrossRef

29.

Stankewitz A, Aderjan D, Eippert F, May A: Trigeminal nociceptive transmission in migraineurs predicts migraine attacks. J Neurosci 2011, 31: 1937–1943. doi:10.1523/JNEUROSCI.4496–10.2011 10.1523/JNEUROSCI.4496-10.2011CrossRefPubMed

30.

Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G: Hypothalamic activation in spontaneous migraine attacks. Headache 2007, 47: 1418–1426. doi:10.1111/j.1526–4610.2007.00776.xPubMed

31.

Aderjan D, Stankewitz A, May A: Neuronal mechanisms during repetitive trigemino-nociceptive stimulation in migraine patients. PAIN 2010, 151: 97–103. doi:10.1016/j.pain.2010.06.024 10.1016/j.pain.2010.06.024CrossRefPubMed

32.

Tracey I: Imaging pain. Br J Anaesth 2008, 101: 32–39. doi:10.1093/bja/aen102 10.1093/bja/aen102CrossRefPubMed

33.

May A: Neuroimaging: visualising the brain in pain. Neurol Sci 2007, 28: S101-S107. doi:10.1007/s10072–007–0760-x 10.1007/s10072-007-0760-xCrossRefPubMed

34.

Fuchs PN, Peng YB, Boyette-Davis JA, Uhelski ML: The anterior cingulate cortex and pain processing. Front Integr Neurosci 2014., 8: doi:10.3389/fnint.2014.00035

35.

Treede RD, Kenshalo DR, Gracely RH, Jones AK: The cortical representation of pain. Pain 1999, 79: 105–111. 10.1016/S0304-3959(98)00184-5CrossRefPubMed

36.

Timmermann L, Ploner M, Haucke K, Schmitz F, Baltissen R, Schnitzler A: Differential coding of pain intensity in the human primary and secondary somatosensory cortex. J Neurophys 2001, 86: 1499–1503.

37.

Gao Y-J, Ren W-H, Zhang Y-Q, Zhao Z-Q: Contributions of the anterior cingulate cortex and amygdala to pain- and fear-conditioned place avoidance in rats. Pain 2004, 110: 343–353. doi:10.1016/j.pain.2004.04.030 10.1016/j.pain.2004.04.030CrossRefPubMed

38.

Bush N, Luu N, Posner N: Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci (Regul Ed) 2000, 4: 215–222. 10.1016/S1364-6613(00)01483-2CrossRef

39.

Straube T, Schmidt S, Weiss T, Mentzel HJ, Miltner WH: Dynamic activation of the anterior cingulate cortex during anticipatory anxiety. NeuroImage 2009, 44: 975–981. doi:10.1016/j.neuroimage.2008.10.022 10.1016/j.neuroimage.2008.10.022CrossRefPubMed

40.

Chen TL, Babiloni C, Ferretti A, Perrucci MG, Romani GL, Rossini PM, Tartaro A, Del Gratta C: Human secondary somatosensory cortex is involved in the processing of somatosensory rare stimuli: An fMRI study. NeuroImage 2008, 40: 1765–1771. doi:10.1016/j.neuroimage.2008.01.020 10.1016/j.neuroimage.2008.01.020CrossRefPubMed

41.

Goadsby PJ, Edvinsson L, Ekman R: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28: 183–187. doi:10.1002/ana.410280213 10.1002/ana.410280213CrossRefPubMed

42.

Katsarava Z, Limmroth V, Baykal O, Akguen D, Diener HC, Kaube H: Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks. Cephalalgia 2004, 24: 657–662. doi:10.1111/j.1468–2982.2004.00730.x 10.1111/j.1468-2982.2004.00730.xCrossRefPubMed

43.

Groppetti A, Braga PC, Biella G, Parenti M, Rusconi L, Mantegazza P: Effect of aspirin on serotonin and met-enkephalin in brain: Correlation with the antinociceptive activity of the drug. Neuropharmacology 1988, 27: 499–505. doi:10.1016/0028–3908(88)90132–3 10.1016/0028-3908(88)90132-3CrossRefPubMed

44.

Göbel H, Ernst M, Jeschke J, Keil R, Weigle L: Acetylsalicylic acid activates antinociceptive brain-stem reflex activity in headache patients and in healthy subjects. Pain 1992, 48: 187–195. doi:10.1016/0304–3959(92)90058-J 10.1016/0304-3959(92)90058-JCrossRefPubMed

Title: Central effects of acetylsalicylic acid on trigeminal-nociceptive stimuli
Authors: Inga L Kröger
Arne May
Publication date: 01-12-2014
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/1129-2377-15-59

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Central effects of acetylsalicylic acid on trigeminal-nociceptive stimuli

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia

Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate

Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiography

Treatment adherence among new triptan users: a 2-year cohort study in Taiwan

Migraine without aura is not associated with incomplete circle of Willis: a case–control study using high-resolution magnetic resonance angiography

Expression of 5-HT3 receptors and TTX resistant sodium channels (NaV1.8) on muscle nerve fibers in pain-free humans and patients with chronic myofascial temporomandibular disorders